Reviva Pharmaceuticals I... (RVPHW)
0.05
-0.00 (-7.41%)
At close: Apr 21, 2025, 3:49 PM
-7.41% (1D)
| Bid | 0.04 |
| Market Cap | 2.33M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| EPS (ttm) | n/a |
| PE Ratio (ttm) | n/a |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 0.07 |
| Volume | 41,670 |
| Avg. Volume (20D) | 32,063.694 |
| Open | 0.06 |
| Previous Close | 0.05 |
| Day's Range | 0.05 - 0.06 |
| 52-Week Range | 0.05 - 0.06 |
| Beta | 0.05 |
About RVPHW
Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is brilaroxazine (RP5063), which is in Phase III clinical trials for use in the treatment of schizophrenia, as ...
Industry Biotechnology
Sector Healthcare
IPO Date n/a
Employees 14
Stock Exchange NASDAQ
Ticker Symbol RVPHW
Website https://www.revivapharma.com